P3 Health Partners Inc expected to post a loss of $8.91 a share - Earnings Preview

P3 Health Partners

13/05/2025 21:59

P3 Health Partners Inc PIII.OQ PIII.O is expected to show a fall in quarterly revenue when it reports  results on May 15 for the period ending March 31 2025

The Chicago Illinois-based  company is expected to report a 7.8% decrease in revenue to $358.346 million from $388.49 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

​LSEG's mean analyst estimate for P3 Health Partners Inc is for a loss of $8.91 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for P3 Health Partners Inc is $20.00​, above​ its last closing price of $8.45. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-4.10
-19.50
Missed
-375.6
Sep. 30 2024
-1.89
-1.87
-14.50
Missed
-673.3
Jun. 30 2024
-3.47
-2.50
-4.50
Missed
-80​
Mar. 31 2024
-5.64
-5.33
-8.00
Missed
-50
​​Dec. 31 2023
-9.50
-5.50
-11.00
Missed
-100
Sep. 30 2023
-14.55
-11.00
-6.00
Beat
45.5​
Jun. 30 2023
-7.11
-6.50
-4.50
Beat
30.8
Mar. 31 2023
-31.54
-33.75
-11.00
Beat
67.4

This summary was machine generated May 13 at 20:59 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)